Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc.（PVLA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pvla · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$255
Consensus
$208
+97.3% upside
Low
$143
Median: $207.5 · Last Close: $105.25
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$207.67
97.3% upside
High Target
$255
142.3%
Low Target
$143
35.9%
Current Price
$105.25
as of today
Based on analyst price targets, the PVLA stock price prediction for the next 12 months ranges from $143 to $255. The consensus PVLA price forecast of $207.67 implies 97.3% upside from the current price of $105.25.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $102.17 | ↓ 2.92% |
1-day model range: $101.29–$103.06. Peak: $103.06 (-2.92%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $232 | +120.0% |
| 2028 | $384 | +265.2% |
| 2029 | $524 | +397.8% |
| 2030 | $629 | +497.1% |
| 2031 | — | +562.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PVLA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-21 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-05-21 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-31 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-16 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-25 | Mizuho | Maintains | Outperform→Outperform |
| 2026-02-25 | BTIG | Maintains | Buy→Buy |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-24 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-29 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Palvella Therapeutics, Inc. (PVLA) stock. Of the recent 42 rating actions, 1 were upgrades and 0 were downgrades. 11 analysts currently cover PVLA.
分析师推荐趋势
PVLA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 9 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$31M
↑ 117601.5% YoY
EPS This Year
$-5.56
EPS Next Year
$-6.43
↑ 15.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast PVLA EPS of $-5.56 for the current fiscal year, based on estimates from 12 analysts. The PVLA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PVLA 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PVLA 的共识目标价为 $207.67（+97.3% 上行空间），分析师共识为 Buy。
PVLA 的短期预测（明日）为 $102.17（-2.92%）。 PVLA 对 2027 年的股价预测均值为 $232。 PVLA 对 2030 年的预测区间为 $569–$688。
Palvella Therapeutics, Inc. 在 NASDAQ 上市，代码 PVLA。PVLA 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
PVLA 预测 · 8 个问题根据 11 位华尔街分析师，PVLA 的 12 个月平均目标价为 $207.67，最高 $255.00、最低 $143.00。若有图表，中位目标价可在上方查看。相对当前价 $105.25，隐含约 +97.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.